News
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
Cigna now offers employers $200 Wegovy, Zepbound copay option. The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
Hosted on MSN1mon
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit - MSNBy Amina Niasse NEW YORK (Reuters) -Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy benefit ...
Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients; The company hopes the new discount, which caps monthly out-of-pocket ...
New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200 By Paige Minemyer May 21, 2025 4:30pm Cigna Evernorth Express Scripts GLP-1 ...
Wegovy and Zepbound costs capped at $200 in new Evernorth programme. Robert Barrie . Thu, May 22, 2025, ... Evernorth, the pharmacy benefits unit for health insurer giant Cigna, ...
Cigna also posted first quarter results well above analyst forecasts. ... That means Wegovy will be available to Caremark members at a lower price, but that other GLP-1s, ...
Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.
Wegovy will now be the GLP-1 weight loss drug of choice under plans that are managed by CVS Caremark. If they stay on Zepbound for their GLP-1 weight loss treatment, they will have to pay full ...
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy benefit management plans, the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results